Funding for this research was provided by:
Knut och Alice Wallenbergs Stiftelse (2018.0172, 2019-0107)
Vetenskapsrådet (2019-01238, 2015-03558, 2019-01360)
Horizon 2020 Framework Programme (681893)
Hjärnfonden (FO2017-0075, FO2018-0162)
Cancerfonden (190394 Pj)
Svenska Sällskapet för Medicinsk Forskning (JUB2019)
Received: 13 October 2021
Accepted: 9 May 2022
First Online: 25 May 2022
: All experimental procedures in this study were conducted in accordance with the European directive 2010/63/EU, local Swedish directive L150/SJVFS/2019:9, Saknr L150, and Karolinska Institutet complementary guidelines for procurement and use of laboratory animals, Dnr 1937/03-640. The procedures described here were approved by Stockholms Norra Djurförsöksetiska nämnd, the local committee for ethical experiments on laboratory animals in Sweden, lic.nr. 130/15, 144/16, and 1995/2019.
: Not applicable
: M.M.H. and M.N. held shares in CartaNA AB, now part of 10x Genomics.